Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma

This publication has 77 references indexed in Scilit:

• Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
  Oncogene, 2013
• Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling
  Science Signaling, 2012
• Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2
  Cell, 2012
• Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
  British Journal of Cancer, 2011
• A TACC3/ch‐TOG/clathrin complex stabilises kinetochore fibres by inter‐microtubule bridging
  The EMBO Journal, 2011
• Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
  British Journal of Cancer, 2009
• Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform
  Journal of Biological Chemistry, 2009
• Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis
  Molecular Cancer Research, 2008
• MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
  Science, 2007
• Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
  Gastroenterology, 2007